This site is intended for Healthcare Professionals only.

Reckitt recalls two infant formula powders over safety concerns

Date:

Share post:

The company has contacted all stores and pharmacies that are supplying these products

Reckitt has recalled certain catches of Nutramigen LGG stage 1 and stage 2 Hypoallergenic Formula powders over the possible presence of Cronobacter sakazakii.

While the products, which are used for special medical purposes for infants, are mainly prescribed, they are also available without a prescription.

The precautionary step has been taken after an isolated overseas sample of the product tested positive for Cronobacter sakazakii, said the consumer goods company, adding that a thorough investigation is on.

Cronobacter sakazakii is a type of bacteria that can easily survive in dry foods, like powdered infant formula, powdered milk, herbal teas, and starches.

The consumer goods company cautioned that the germ can cause fever and diarrhoea, and in severe cases may lead to sepsis or meningitis, which can cause symptoms like poor feeding, irritability, temperature changes, jaundice (yellow skin and whites of the eyes) and abnormal breaths and movements in infants.

The products being recalled are:

  • Nutramigen LGG Stage 1 Hypoallergenic Formula (400g), batch code ZL3F7D, Expiry date – 1st July 2025
  • Nutramigen LGG Stage 2 Hypoallergenic Formula (400g), batch code ZL3FAA, Expiry date – 1st July 2025
  • Nutramigen LGG Stage 2 Hypoallergenic Formula (400g), batch code ZL3FDM, Expiry date – 1st July 2025

They have contacted all stores and pharmacies that are supplying these products, as well as issued a recall notice to its customers.

“If you have purchased or been prescribed any of the above product batches, do not feed it to your baby and return to the place of purchase.

“If you have any concerns about the health of your baby, please seek medical advice,” the company said.

Reckitt has confirmed that no other batches of Nutramigen LGG Stage 1 and stage 2, and no other Nutramigen products in the range are affected, and these remain safe to use.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Northern Ireland releases plan to fully realise the potential of community pharmacies

NI Community Pharmacy Strategic Plan 2030 envisions an expansion of clinical services offered by community pharmacies The Department...

Britain refuses to sign WHO pandemic accord over vaccine sharing

As per the pandemic accord, 20 % of tests, treatments and vaccines to be shared among poorer countries  Britain...

Medicine supply problems ‘a daily occurrence in pharmacies across England’

97% of pharmacy team members surveyed reported patient frustration due to medicine supply issues A report released by...

Alarming Stats: 1 in 2 British children feel low confidence due to their teeth’s appearance

Missing, discoloured, and crooked teeth top reasons for children's smile insecurities A new study by oral health brand...